Abstract
The identification of genetic variants in APOL1 as a major driver of kidney disease in blacks has ushered in an exciting new era in glomerular disease, offering the potential for precision medicine in a range of kidney diseases in individuals with sub-Saharan African ancestry ([1][1]). The presence
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have